Health Care & Life Sciences » Biotechnology | Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
112,025.00
161,078.00
29,531.00
2,088,800.00
51,940.00
Depreciation, Depletion & Amortization
100,796.00
114,468.00
84,057.00
339,562.00
-
Other Funds
1,539.00
1,870.00
7,599.00
2,488.00
2,212.00
Funds from Operations
20,599.00
46,416.00
14,103.00
33,780.00
49,312.00
Changes in Working Capital
32,760.00
62,583.00
31,087.00
22,106.00
123,159.00
Net Operating Cash Flow
12,161.00
108,999.00
16,984.00
55,886.00
73,847.00
Capital Expenditures
60,819.00
71,093.00
697,730.00
401,897.00
900.00
Sale of Fixed Assets & Businesses
-
19,344.00
-
-
-
Purchase/Sale of Investments
44,968.00
85,191.00
90,305.00
51,303.00
6,003.00
Net Investing Cash Flow
136,903.00
21,835.00
607,709.00
458,490.00
6,278.00
Cash Dividends Paid - Total
30,026.00
67.00
31.00
5.00
-
Issuance/Reduction of Debt, Net
48,864.00
165,673.00
93,923.00
1,573,307.00
136,088.00
Net Financing Cash Flow
464,540.00
163,736.00
286,671.00
2,145,528.00
138,300.00
Net Change in Cash
342,091.00
88,823.00
340,294.00
1,630,187.00
71,225.00
Free Cash Flow
46,582.00
165,778.00
712,376.00
454,514.00
72,947.00
Net Assets from Acquisitions
123,919.00
-
-
-
-
Other Sources
3,996.00
3,367.00
-
-
625.00
Change in Capital Stock
544,969.00
-
200,378.00
574,716.00
-
Exchange Rate Effect
2,293.00
12,251.00
2,272.00
965.00
494.00
Other Uses
1,129.00
14,974.00
284.00
5,290.00
-

About Immuno-Biological Laboratories Co.

View Profile
Address
1091-1 Naka Aza-Higashida
Fujioka Gumma 375
Japan
Employees -
Website http://www.ibl-japan.co.jp
Updated 09/14/2018
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.